From March 24, 2024 to March 31, 2024, the company has repurchased 3,275,199 shares, representing 6.96% for $1,000 million. With this, the company has completed the repurchase of 3,275,199 shares, representing 6.96% for $1,000 million under the buyback announced on March 25, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
275.1 USD | +1.73% | +0.82% | +25.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.12% | 12.21B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- Tranche Update on United Therapeutics Corporation's Equity Buyback Plan announced on March 25, 2024.